These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32525839)

  • 1. Increased systemic sST2 in patients with end stage renal disease contributes to milder liver damage during HCV infection.
    Lukic R; Cupic M; Gajovic N; Jurisevic M; Mijailovic Z; Davidovic B; Kujundzic B; Joksimovic B; Arsenijevic N; Jovanovic I
    J Infect Dev Ctries; 2020 May; 14(5):519-526. PubMed ID: 32525839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Hepatoprotective Role of Galectin-3 during HCV Infection in End-Stage Renal Disease Patients.
    Lukic R; Gajovic N; Jovanovic I; Jurisevic M; Mijailovic Z; Maric V; Popovska Jovicic B; Arsenijevic N
    Dis Markers; 2017; 2017():6275987. PubMed ID: 28487598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of soluble ST2, but not IL-33, correlate with the severity of alcoholic liver disease.
    Sun Z; Chang B; Huang A; Hao S; Gao M; Sun Y; Shi M; Jin L; Zhang W; Zhao J; Teng G; Han L; Tian H; Liang Q; Zhang JY; Zou Z
    J Cell Mol Med; 2019 Feb; 23(2):887-897. PubMed ID: 30478965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum soluble ST2 is a promising prognostic biomarker in HBV-related acute-on-chronic liver failure.
    Jiang SW; Wang P; Xiang XG; Mo RD; Lin LY; Bao SS; Lu J; Xie Q
    Hepatobiliary Pancreat Dis Int; 2017 Apr; 16(2):181-188. PubMed ID: 28381383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. End-stage renal disease and hepatitis C infection: comparison of alanine aminotransferase levels and liver histology in patients with and without renal damage.
    Contreras AM; Ruiz I; Polanco-Cruz G; Monteón FJ; Celis A; Vázquez G; Gómez-Herrera E; García-Correa JE; Male-Velázquez R; Ruelas-Hernández S
    Ann Hepatol; 2007; 6(1):48-54. PubMed ID: 17297429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ST2 as a novel prognostic marker in end-stage renal disease patients on hemodiafiltration.
    Homsak E; Ekart R
    Clin Chim Acta; 2018 Feb; 477():105-112. PubMed ID: 29221927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble ST2 plasma concentrations predict mortality in HBV-related acute-on-chronic liver failure.
    Lei Z; Mo Z; Zhu J; Pang X; Zheng X; Wu Z; Wang K; Li X; Xie D; Gao Z
    Mediators Inflamm; 2015; 2015():535938. PubMed ID: 25892854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of impact of hepatitis C virus coinfection in end-stage renal disease patients with hepatitis B virus infection.
    Moutinho RS; Perez RM; Pace FH; Ferreira AS; Cendoroglo M; Medina-Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
    Transplant Proc; 2005 Jun; 37(5):2080-2. PubMed ID: 15964344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-33/ST2 signaling contributes to the severity of hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.
    Yamada S; Shimizu M; Kuroda M; Inoue N; Sugimoto N; Yachie A
    Clin Exp Nephrol; 2019 Apr; 23(4):544-550. PubMed ID: 30467800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum levels of IL-33 and soluble ST2 in neonates with human cytomegalovirus infection.
    Chen Y; Qian J
    J Med Virol; 2018 Aug; 90(8):1383-1388. PubMed ID: 29663450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus (HCV) and chronic renal disease.
    Ayodele OE; Salako BL
    Afr J Med Med Sci; 2003 Sep; 32(3):287-91. PubMed ID: 15030090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and laboratory characteristics of acute hepatitis C in patients with end-stage renal disease on hemodialysis.
    Lemos LB; Perez RM; Matos CA; Silva IS; Silva AE; Ferraz ML
    J Clin Gastroenterol; 2008 Feb; 42(2):208-11. PubMed ID: 18209594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of serum sST2 is associated with poor prognosis in acute-on-chronic hepatitis B liver failure.
    Gao S; Huan SL; Han LY; Li F; Ji XF; Li XY; Fan YC; Wang K
    Clin Res Hepatol Gastroenterol; 2015 Jun; 39(3):315-23. PubMed ID: 25481239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) axis in idiopathic inflammatory myopathies and its association with laboratory and clinical parameters: a pilot study.
    Opinc A; Sarnik J; Brzezińska O; Makowski M; Lewandowska-Polak A; Makowska J
    Rheumatol Int; 2020 Jul; 40(7):1133-1141. PubMed ID: 32222805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation.
    Sterling RK; Sanyal AJ; Luketic VA; Stravitz RT; King AL; Post AB; Mills AS; Contos MJ; Shiffman ML
    Am J Gastroenterol; 1999 Dec; 94(12):3576-82. PubMed ID: 10606322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Expression of Interleukin-33/ST2 Predicts the Progression and Poor Prognosis in Chronic Hepatitis B Patients with Hepatic Flare.
    Yuan W; Mei X; Zhang YY; Zhang ZG; Zou Y; Zhu H; Liu Y; Wang JF; Qian ZP; Lu HZ
    Am J Med Sci; 2020 Dec; 360(6):656-661. PubMed ID: 32988596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of ST2 and ST2 genetic variants in schistosomiasis.
    Long X; Daya M; Zhao J; Rafaels N; Liang H; Potee J; Campbell M; Zhang B; Araujo MI; Oliveira RR; Mathias RA; Gao L; Ruczinski I; Georas SN; Vercelli D; Beaty TH; Barnes KC; Chen X; Chen Q
    J Allergy Clin Immunol; 2017 Nov; 140(5):1416-1422.e6. PubMed ID: 28189770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-33/ST2 pathway regulates neutrophil migration and predicts outcome in patients with severe alcoholic hepatitis.
    Artru F; Bou Saleh M; Maggiotto F; Lassailly G; Ningarhari M; Demaret J; Ntandja-Wandji LC; Pais de Barros JP; Labreuche J; Drumez E; Helou DG; Dharancy S; Gantier E; Périanin A; Chollet-Martin S; Bataller R; Mathurin P; Dubuquoy L; Louvet A
    J Hepatol; 2020 Jun; 72(6):1052-1061. PubMed ID: 31953139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of concomitant hepatitis C virus infection in patients with underlying lupus nephritis on long-term renal outcome.
    Mitwalli AH; Hayat A; Alwakeel J; Hammad D
    Nephrol Dial Transplant; 2012 Feb; 27(2):627-32. PubMed ID: 21771749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Levels of Soluble ST2 and IL-10 Are Associated with Disease Severity in Patients with IgA Nephropathy.
    Zhang Z; Wang H; Zhang L; Crew R; Zhang N; Liu X; Jiang Y
    J Immunol Res; 2016; 2016():6540937. PubMed ID: 27900334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.